SK660487A3 - PYRIDO£3,2,1-IJ|-1,3,4-BENZOXADIAZINE DERIVATIVES, METHOD FORì PRODUCING SAME, AND PHARMACEUTICAL COMPOSITIONS ON THEIR BASE - Google Patents

PYRIDO£3,2,1-IJ|-1,3,4-BENZOXADIAZINE DERIVATIVES, METHOD FORì PRODUCING SAME, AND PHARMACEUTICAL COMPOSITIONS ON THEIR BASE Download PDF

Info

Publication number
SK660487A3
SK660487A3 SK6604-87A SK660487A SK660487A3 SK 660487 A3 SK660487 A3 SK 660487A3 SK 660487 A SK660487 A SK 660487A SK 660487 A3 SK660487 A3 SK 660487A3
Authority
SK
Slovakia
Prior art keywords
methyl
pyrido
fluoro
oxo
dihydro
Prior art date
Application number
SK6604-87A
Other languages
English (en)
Slovak (sk)
Other versions
SK278990B6 (sk
Inventor
Masahiro Aoki
Miyako Kamata
Tatsuo Ohtsuka
Nobuo Shimma
Kazuteru Yokose
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SK660487A3 publication Critical patent/SK660487A3/sk
Publication of SK278990B6 publication Critical patent/SK278990B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK6604-87A 1986-09-12 1987-09-11 Pyrido[3,2,1-ij]-1,3,4-benzoxadiazínové deriváty, SK278990B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP86112619 1986-09-12

Publications (2)

Publication Number Publication Date
SK660487A3 true SK660487A3 (en) 1998-05-06
SK278990B6 SK278990B6 (sk) 1998-05-06

Family

ID=8195410

Family Applications (1)

Application Number Title Priority Date Filing Date
SK6604-87A SK278990B6 (sk) 1986-09-12 1987-09-11 Pyrido[3,2,1-ij]-1,3,4-benzoxadiazínové deriváty,

Country Status (22)

Country Link
JP (3) JPH0696578B2 (cs)
KR (1) KR960002857B1 (cs)
CN (1) CN1017800B (cs)
AT (1) AT389119B (cs)
AU (1) AU602534B2 (cs)
CA (1) CA1336905C (cs)
CZ (1) CZ281195B6 (cs)
DK (1) DK173330B1 (cs)
DZ (1) DZ1124A1 (cs)
FI (1) FI86428C (cs)
HU (1) HU199481B (cs)
IE (1) IE61624B1 (cs)
IL (1) IL83814A (cs)
MC (1) MC1850A1 (cs)
MX (1) MX8302A (cs)
NO (1) NO169125C (cs)
NZ (1) NZ221681A (cs)
PH (1) PH23930A (cs)
PT (1) PT85686B (cs)
SK (1) SK278990B6 (cs)
ZA (1) ZA876636B (cs)
ZW (1) ZW16387A1 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW16387A1 (en) * 1986-09-12 1988-05-25 Hoffmann La Roche Tricyclic compounds
EP1757598A4 (en) 2004-05-13 2010-07-21 Daiichi Seiyaku Co SUBSTITUTED PYRROLIDINE DERIVATIVE
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
PL2383271T3 (pl) 2006-03-13 2013-12-31 Kyorin Seiyaku Kk Aminochinolony jako inhibitory GSK-3
MX2010002667A (es) 2007-09-11 2010-04-01 Activx Biosciences Inc Cianoaminoquinolonas y tetrazoloaminoquinolonas como inhibidores de gsk-3.
BRPI0816814B1 (pt) 2007-09-12 2021-08-31 Kyorin Pharmaceutical Co. Ltd Composto, composição farmacêutica e uso de um composto
FR2928150A1 (fr) * 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
AU2010221990B2 (en) 2009-03-11 2015-06-04 Kyorin Pharmaceutical Co., Ltd. 7-cycloalkylaminoquinolones as GSK-3 inhibitors
CN107522718B (zh) * 2017-09-14 2019-11-08 浙江国邦药业有限公司 一种马波沙星的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW16387A1 (en) * 1986-09-12 1988-05-25 Hoffmann La Roche Tricyclic compounds

Also Published As

Publication number Publication date
DK477287D0 (da) 1987-09-11
IE61624B1 (en) 1994-11-16
AU7811487A (en) 1988-03-17
FI873940A (fi) 1988-03-13
MC1850A1 (fr) 1988-09-30
AT389119B (de) 1989-10-25
HU199481B (en) 1990-02-28
JPH07138256A (ja) 1995-05-30
CN1017800B (zh) 1992-08-12
DK477287A (da) 1988-03-13
MX8302A (es) 1993-12-01
JPS63132891A (ja) 1988-06-04
CZ281195B6 (cs) 1996-07-17
ATA263887A (de) 1989-03-15
PT85686B (pt) 1990-05-31
JPH0819120B2 (ja) 1996-02-28
SK278990B6 (sk) 1998-05-06
PT85686A (en) 1987-10-01
FI873940A0 (fi) 1987-09-11
NZ221681A (en) 1990-12-21
KR960002857B1 (ko) 1996-02-27
JPH0826030B2 (ja) 1996-03-13
KR880003954A (ko) 1988-06-01
HUT47294A (en) 1989-02-28
FI86428B (fi) 1992-05-15
AU602534B2 (en) 1990-10-18
ZA876636B (en) 1988-07-27
FI86428C (fi) 1992-08-25
NO873816D0 (no) 1987-09-11
CA1336905C (en) 1995-09-05
DK173330B1 (da) 2000-07-24
JPH0696578B2 (ja) 1994-11-30
ZW16387A1 (en) 1988-05-25
IL83814A (en) 1991-09-16
NO873816L (no) 1988-03-14
PH23930A (en) 1990-01-23
NO169125B (no) 1992-02-03
IE872444L (en) 1988-03-12
JPH07138262A (ja) 1995-05-30
CN87106838A (zh) 1988-05-11
NO169125C (no) 1992-05-13
DZ1124A1 (fr) 2004-09-13
CZ660487A3 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
US4801584A (en) Pyrido(3,2,1-IJ)-1,3,4 benzoxadiazine derivatives
US4843070A (en) Substituted thiazetoquinoline-3-carboxylic acids and pharmaceutically acceptable salts thereof
CZ192892A3 (en) Derivatives of 7-azaisoindolinyl-quinolonecarboxylic and naphthyridonecarboxylic acids
HU179927B (en) Process for preparing naphthyridine derivatives
PL127762B1 (en) Process for preparing novel derivatives of 1,8-naptiridine
EP0154780B1 (en) Quinoline antibacterial compounds
SK660487A3 (en) PYRIDO£3,2,1-IJ|-1,3,4-BENZOXADIAZINE DERIVATIVES, METHOD FORì PRODUCING SAME, AND PHARMACEUTICAL COMPOSITIONS ON THEIR BASE
US4473568A (en) Antibacterial thiazolidine or thiomorpholine substituted quinolines
NO862042L (no) Antibakterielt virksomme chinolonkarboksylsyreestere.
US4864023A (en) Pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives
EP0160284B1 (en) Quino-benoxazine antibacterial compounds
IE860062L (en) Naphthyridines and pyridines
US4616019A (en) Naphthyridine antibacterial compounds
US4607032A (en) Quino-benoxazine antibacterial compounds
US4533663A (en) Quino-benzothiazine antibacterial compounds
US4774246A (en) Quinoline antibacterial compounds
EP0162333B1 (en) Quino-benzothiazine antibacterial compounds
FI88041B (fi) Pyrido/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat
CA1340782C (en) Naphthyridone antibacterial compounds
KR940008420B1 (ko) 신규한 퀴놀론계 화합물과 그 제조 방법
NO171162B (no) Pyrido-benzoksadiazinderivater
CS235545B2 (cs) Způsob přípravy derivátů 1-ethyl nebo vinyl-6-halogen-1,4-dihydro-4- oxo-7-/1 -piperazinyl/-!,8-nafthyridinu
HU190779B (en) Process for producing quinoline-carboxylic acid derivatives